Comparison of the effect of orlistat with and without levocarnitine on insulin resistance in obese patients with type 2 diabetes mellitus inadequately controlled with insulin or oral antihyperglycaemics.

Trial Profile

Comparison of the effect of orlistat with and without levocarnitine on insulin resistance in obese patients with type 2 diabetes mellitus inadequately controlled with insulin or oral antihyperglycaemics.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2011

At a glance

  • Drugs Levocarnitine (Primary) ; Orlistat (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Oct 2011 Results published in Fundamental and Clinical Pharmacology.
    • 12 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top